Clinical Observation of Magnesium Sulfate Combined with Nifedipine and Labetalol in the Treatment of Hypertensive Disorder Complicating Pregnancy  

硫酸镁联合硝苯地平、拉贝洛尔治疗妊娠期高血压的临床疗效观察

作　　者：QIU Lijuan 

机构地区：[1]Chongqing Bishan Maternal and Child Health Hospital, Chongqing 402760, China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2021年第6期078-080,共5页

摘　　要：Objective: to observe the therapeutic effect of nifedipine and magnesium sulfate combined with labetalol in the clinical treatment of pregnant women with pregnancy induced hypertension. Methods: the time of this study was chosen from January to December 2019. The study population selected 98 pregnant women with pregnancy-induced hypertension and all of them came to our hospital for treatment. The 98 pregnant women were divided into two groups with the same number by letters. The pregnant women named as the observation group were treated with nifedipine and magnesium sulfate combined with labetalol, while the pregnant women in the other group were not treated with labetalol. After different treatments, the blood pressure values such as diastolic pressure and systolic pressure of pregnant women were observed and recorded, and the complications occurred in the treatment of the two groups of pregnant women were counted. Results: after taking different nursing management interventions, the complications of pregnant women with pregnancy-induced hypertension in the observation group were significantly better than those of pregnant women with pregnancy-induced hypertension in the control group. At the same time, the blood pressure indexes of the patients in the observation group were better and the treatment effect was more significant. All the data generated between the two groups had significant difference after medical statistics comparison (P < 0.05). Conclusion: nifedipine and magnesium sulfate combined with labetalol in the treatment of pregnant women with hypertensive disorder complicating pregnancy can improve the therapeutic effect on patients, reduce the occurrence of complications of patients, reduce various blood pressure indicators of patients, and have higher therapeutic safety, which is worthy of wide clinical application.

关 键 词：magnesium sulfate NIFEDIPINE LABETALOL hypertension during pregnancy treatment effect 

分 类 号：R714.246[医药卫生—妇产科学]